ALK Biomarkers News and reporting on ALK biomarkers. Takeda's Alunbrig Gets First-Line FDA Approval With Abbott CDx in ALK-Positive Lung Cancer The approval was based on data showing superior efficacy for Alunbrig compared to Pfizer's Xalkori, especially in patients with brain metastasis. Genetron Health Obtains Regulatory Approval in China for NGS Instrument, Lung Cancer Panel The high-throughput S2000 sequencer is the second instrument Genetron Health has received NMPA approval for, following the S5 benchtop instrument last year. Inivata to Employ Liquid Biopsy Test in EORTC Phase II NSCLC Study of Lorlatinib The company will use its InVisionFirst-Lung test to study resistance mutations in patients treated with Pfizer's ALK inhibitor lorlatinib. Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines Premium An IASLC survey showed that molecular testing is not performed in line with expert guidelines, which means only a minority of lung cancer patients are benefitting from precision oncology. IncellDx Inks Chinese Collaboration, Distribution Agreements As part of the agreement, Kindstar will use InCellDx's single-cell immuno-oncology and oncology diagnostic products in China, including Hong Kong and Macao. Jul 18, 2019 Inivata to Test Liquid Biopsy Against Tissue Sequencing in French Prospective Clinical Trial Jun 18, 2019 Next-Generation Sequencing of Pediatric Cancer Patients Could Transform Treatment Paradigms Premium May 16, 2019 Roche Drug Shows Benefit in Pediatric Patients With Rare, Molecularly Defined Tumors Premium Apr 10, 2019 Foundation Medicine, Flatiron Health Publish Clinical Validity of Clinico-Genomics Database Dec 19, 2018 FDA CDx Class Labeling Draft Guidance May Ease Patient Access, Spur Competition Among Test Makers Premium Nov 1, 2018 Almac Developing Next-Generation Sequencing Assay for TP Therapeutics' Anti-Tumor Therapy Premium Oct 31, 2018 Lung Cancer Panel From PlexBio Receives CE Mark Oct 12, 2018 AmoyDx Lung Cancer CDx Approved in South Korea Nov 3, 2017 CMS 14-Day Rule Revisions Ease Precision Medicine Access for Patients, Stakeholders Say Premium Oct 16, 2017 Moffitt Team Uses Proteomic Profiling to ID New Ceritinib Targets in Lung Cancer Premium Sep 14, 2017 New Genetic Variant Discovered to Cause Peritoneal Mesothelioma Sep 7, 2017 Patient Advocacy Strategies Evolve as Genomic Advances Change Understanding of Cancer Aug 17, 2017 Biocept, UT Southwestern Partner for ALK Liquid Biopsy Study Aug 15, 2017 ASCO Updates NSCLC Guidelines With New Directives for Genomic Testing Jun 6, 2017 New Precision Oncology Options Emerge at ASCO in First-Line EGFR-Mutated, ALK-Positive Lung Cancer Premium Jun 1, 2017 Roche ALK Test Gains FDA Approval as CDx for Zykadia May 30, 2017 Novartis' Zykadia Approved for Frontline Treatment of Metastatic, ALK-Positive NSCLC May 15, 2017 HTG Molecular's Q1 Revenues Increase 62 Percent Mar 23, 2017 HTG Molecular Gets CE Mark for Lung Cancer CDx Oct 20, 2016 Moffitt, University of Colorado Teams Identify ALK Inhibitor Sensitizers in Lung Cancer Premium Load More Breaking News Canadian Healthcare Providers, Policymakers Value Different Aspects of Clinical Genomic Sequencing New Products Posted to GenomeWeb: Oxford Nanopore, Bio-Rad, NanoString, More People in the News at OraSure, Element Biosciences, Micronoma, More Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More Illumina, Precision Health Research Singapore Partner for 100K Genomes Population Study The Scan Blend of Omicron With Delta The Associated Press reports that currently circulating Omicron variants have some features previously seen in the Delta variant. Limited Contrast The New York Times reports that there is a shortage of a contrast agent used for some medical scans. Pig Improvement Farmers in China are using genetics to improve their hog herds, according to Reuters. Science Papers Present Way to Molecularly Classify Prostate Cancer, Saliva-Based SARS-CoV-2 Test, More In Science this week: approach to molecularly classify prostate tumors, saliva-based test for SARS-CoV-2, and more.